Skip to main content

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Full Results from Phase 1 Clinical Trial of PB2452

Read More

1 5 6 7